Liver Cirrhosis clinical trials

Explore recruiting liver cirrhosis clinical trials.

Recruiting liver cirrhosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Liver Cirrhosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

An Open-label Phase 1/2 Multicentre Study to Evaluate the Safety, Tolerability and Efficacy of RTX001 Autologous Macrophages in Participants with Liver Cirrhosis who have Hepatic Decompensation (EMERALD)

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

ALBUMINUS: Dose reduction of human albumin during large-volume paracentesis in patients with cirrhosis

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Denmark, Belgium, Spain, Netherlands, Germany, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)

Germany

Phase III and phase IV (Integrated) EU CTIS Study details

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

Hungary, Netherlands, Spain, Germany, Belgium, Denmark +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Liver Cirrhosis trials by city

Liver Cirrhosis in Toronto Liver Cirrhosis in Vancouver Liver Cirrhosis in Montreal Liver Cirrhosis in Calgary Liver Cirrhosis in Edmonton Liver Cirrhosis in Ottawa Liver Cirrhosis in Winnipeg Liver Cirrhosis in Quebec City Liver Cirrhosis in Hamilton Liver Cirrhosis in Kitchener Liver Cirrhosis in London Liver Cirrhosis in Halifax Liver Cirrhosis in New York Liver Cirrhosis in Los Angeles Liver Cirrhosis in Chicago Liver Cirrhosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease